Diabetes Research
Nearby schools & colleges
866 The Queensway
See what is trending in Diabetes Care. Share your tips on prevention and better management of diabetes.
01/26/2024
Thrilled to represent Obesity Matters in the preparatory discussions for World Obesity Day on March 4th. This year’s theme, « Let’s Talk About Obesity and_____ » is incredibly relevant. Considering the myriad ways obesity is connected to mental health, diabetes, CVD, sleep disorders, nutrition, physical activity, policy, and especially its impact on youth, it’s crucial we initiate and broaden this important dialogue.
It was inspiring to witness global representation, with participants driven by a mission to shift the narrative and make a tangible difference in the lives of those living with this chronic condition.
As World Obesity Day approaches, let’s unite in our efforts to understand, empathize, and support those impacted by obesity. Together, we can break down barriers and bring about positive change.
01/17/2024
Today held its first advisory board meeting of 2024. The discussions were vibrant and insightful, especially on the topic of access to treatment. Having advocates with lived experiences at the table brought unique and valuable perspectives, differentiating from traditional views.
This is what ignites our passion at OM - bringing patient voices to the forefront and challenging conventional norms. Their contributions are essential in shaping our direction and future projects. Stay tuned for exciting initiatives and events on the horizon! 🚀
I’m immensely grateful for our incredible team of advisors and directors, whose strategic guidance is invaluable. 💪
06/06/2023
Research centres in Canada are conducting clinical trials exploring the efficacy and safety of an investigational medication in participants with type 2 diabetes compared to other existing treatment options when treatment is initiated early.
Eligibility:
• Been diagnosed with type 2 diabetes within the last 4 years
• Have HbA1c value between ≥ 7.0% and ≤9.5%
• Have been on a stable metformin treatment for at least 3 months before entering the study.
Qualified participants will receive no-cost study medication, study-related care and up to $1,350 in reimbursement.
If you would like to learn more about this opportunity, connect with us today!
Tel: 1-877-885-0808
Click here to claim your Sponsored Listing.